Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2000
10/26/2000DE19918619A1 Process for obtaining recombinant hepatitis B surface antigen from methylotrophic yeast cells uses high-pressure homogenisation to fracture the cells
10/26/2000DE19917841A1 Structure with nanometer-scale organization, useful as arrays for performing hybridization assays, contains highly ordered polymers fixed at at least two points
10/26/2000CA2758956A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370609A1 Adipocyte complement related protein homolog zacrp3
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370584A1 Methods for enhancing plant defense
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370566A1 Proteins that regulate systemic acquired resistance in plants
10/26/2000CA2370521A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370246A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000CA2370142A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2369969A1 Method of identifying toxic agents using differential gene expression
10/26/2000CA2369961A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000CA2369820A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000CA2369478A1 Compound screening methods
10/26/2000CA2369470A1 Method for detecting and modifying mismatches and mutations in nucleic acid
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2368590A1 Human hac3
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2365707A1 Compound screening method
10/26/2000CA2365424A1 Prevention, diagnosis and treatment of lyme disease
10/26/2000CA2365220A1 Transformed cells useful for the control of pests
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2364191A1 Parasite antigens
10/25/2000EP1046711A2 Recombinant adeno-associated virus
10/25/2000EP1046710A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
10/25/2000EP1046708A1 Expression of bacterial potassium channels in eukaryotic host cells and their use for the identification of antibiotics
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045921A2 Feline immunodeficiency virus gene therapy vectors
10/25/2000EP1045918A1 G protein-related kinase mutants in essential hypertension
10/25/2000EP1045915A2 Regulation of biological events using multimeric chimeric proteins
10/25/2000EP1045910A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
10/25/2000EP1045909A1 Hm2 cDNA RELATED POLYPEPTIDES AND METHODS OF USE
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045903A1 Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof
10/25/2000EP1045900A2 Mammalian alpha helical protein-1
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045860A2 Methods and compositions for treating and diagnosing insulin related disorders
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045857A1 MULTIPLE DRUG RESISTANCE GENE atrC OF ASPERGILLUS NIDULANS
10/25/2000EP1045702A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP1045631A1 Plant senescence-associated genes
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000EP0674711A4 Developmental regulation in anther tissue of plants
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271388A Seed plants characterized by delayed seed dispersal
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271384A Method for influencing the P53 linkage in target genes
10/25/2000CN1271365A Compounds with anti-KS and anti-HIV activity
10/25/2000CN1271364A Isolated proteins having retinol dehydrogenase activity and which associate with retinol binding protein receptors
10/25/2000CN1271018A Process for producing L-glutamic acid
10/25/2000CN1271015A Whole-length gene sequence of donkey leucocytic hyptoxic vaccine strain for horse's infectious anemia (EIAV)
10/25/2000CN1271012A New human cation transfer related protein and its code sequence
10/25/2000CN1271011A New human phosphoric triesterase related protein and its code sequence
10/25/2000CN1271010A New human aromatic esterase protein and its code sequence
10/25/2000CN1271009A New human diacyl glyceropyrophosphate phosphatase protein and its code sequence
10/25/2000CN1271008A New human salt-resisting protein subunit protein and its code sequence
10/25/2000CN1271007A New human chitinase protein and its code sequence
10/25/2000CN1271006A New human proteinase subunit protein and its code sequence
10/25/2000CN1271005A New human cytochrome protein and its code sequence
10/25/2000CN1270839A Antigenic antibody vaccine of foot-and-mouth disease
10/25/2000CN1057775C Anti-thrombus active peptide and preparation method thereof
10/25/2000CN1057774C 乙型肝炎疫苗 Hepatitis B Vaccine
10/24/2000US6137033 Nucleotide sequence which codes an insecticidal polypeptide; for the induction of apoptosis and use as a pesticides
10/24/2000US6137032 Xylanase obtained from an anaerobic fungus
10/24/2000US6137031 Nucleic acid construct coding a transcription factor associated with prevention of infection by microorganism; microbicides
10/24/2000US6137030 Nucleotide sequence coding a pokeweed antiviral protein mutant with reduced phytotoxicity; for preventing viral and fungal infection
10/24/2000US6137029 Chimeric gene formed by fusion of the promoter of pepck (p-enolpyruvate carboxyquinase) to the structural gene of human insulin; allows physiologically regulated production of human insulin, in a tissue different from the pancreas
10/24/2000US6136963 Parasitic helminth DiAg2 nucleic acid molecules, and uses thereof
10/24/2000US6136958 Immunoglobulins which bind preferential mammalian polypeptide; for the treatment of cancer; anticarcinogenic agents
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136955 Mammalian polypeptide associated with spindle and centromers; for the diagnosis, prevention and treatment of cell proliferation defects
10/24/2000US6136954 Polypeptide which activates transcription in eucaryotic cells in the presence of antibiotic; for analysis of cellular proteins
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136952 Human jagged polypeptide, encoding nucleic acids and methods of use
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136786 Analgesics produced by opiates from omega-conopeptides
10/24/2000US6136782 Multimeric antithrombotic agents
10/24/2000US6136779 Methods of specifically transcriptionally modulating the expression of gene of interest
1 ... 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 ... 2916